ARCHIVES

Centocor Withdraws Yondelis After FDA Calls for New Study

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Trial Tests Selenium, Vitamin E In Prostate Cancer Prevention.

July 27, 2001

Human Protein Index Stirs NCI, NCAB Interest, Fires Up Growing Controversy

August 7, 1981

DCT Board Approves Concepts For New CTEP, RRP Grants

February 24, 1989

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003